These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 16797252)
21. Monoamine oxidase A rather than monoamine oxidase B inhibition increases nicotine reinforcement in rats. Guillem K; Vouillac C; Azar MR; Parsons LH; Koob GF; Cador M; Stinus L Eur J Neurosci; 2006 Dec; 24(12):3532-40. PubMed ID: 17229101 [TBL] [Abstract][Full Text] [Related]
22. Tribulin and endogenous MAO-inhibitory regulation in vivo. Medvedev AE; Glover V Neurotoxicology; 2004 Jan; 25(1-2):185-92. PubMed ID: 14697893 [TBL] [Abstract][Full Text] [Related]
23. Potentiation of 3,4-methylenedioxymethamphetamine-induced 5-HT release in the rat substantia nigra by clorgyline, a monoamine oxidase A inhibitor. Hewton R; Salem A; Irvine RJ Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1051-7. PubMed ID: 17714093 [TBL] [Abstract][Full Text] [Related]
24. [Monoamine oxidase activity in rat liver in vitamin B12 deficiency]. Gessler NN; Fedotcheva NI; Foĭgel' AG; Alekseeva NV; Kondrashova MN; Bykhovskiĭ VIa Biokhimiia; 1995 Jun; 60(6):981-6. PubMed ID: 7654868 [TBL] [Abstract][Full Text] [Related]
25. [Monoamine oxidase activity in autonomic ganglia of rabbits with differing resistance of cardiovascular functions to emotional stress]. Gorbunova AV; Kashtanov SI Biull Eksp Biol Med; 1983 Oct; 96(10):111-3. PubMed ID: 6684958 [TBL] [Abstract][Full Text] [Related]
26. [Effect of acute and chronic ethanol consumption on rat brain and liver monoamine oxidase activity]. Romanova LA Vopr Med Khim; 1980; 26(2):252-5. PubMed ID: 7192903 [TBL] [Abstract][Full Text] [Related]
27. Rat strain differences in stereospecific 2-oxidation of RS-8359, a reversible and selective MAO-A inhibitor, by aldehyde oxidase. Sasaki T; Masubuchi A; Yamamura M; Watanabe N; Hiratsuka M; Mizugaki M; Itoh K; Tanaka Y Biopharm Drug Dispos; 2006 Jul; 27(5):247-55. PubMed ID: 16586463 [TBL] [Abstract][Full Text] [Related]
28. Effect of chlorpromazine, imipramine and lithium on MAO-A and MAO-B activity in rat brain mitochondria. Nag M Indian J Exp Biol; 2004 Sep; 42(9):941-4. PubMed ID: 15462192 [TBL] [Abstract][Full Text] [Related]
30. Reversal of stress-induced deficit in aggression by monoamine oxidase inhibitors. Ossowska G; Klenk-Majewska B; Danilczuk Z; Wróbel A; Zebrowska-Lupina I Pol J Pharmacol; 1999; 51(5):391-7. PubMed ID: 10817539 [TBL] [Abstract][Full Text] [Related]
31. Type B monoamine oxidase activity in human brain malignant tumors. Marcozzi G; Befani O; Mondovì B Cancer Biochem Biophys; 1998 Oct; 16(3):287-94. PubMed ID: 10072212 [TBL] [Abstract][Full Text] [Related]
32. Increase of brain endogenous monoamine oxidase inhibitory activity (tribulin) in experimental audiogenic seizures in rats: evidence for a monoamine oxidase A inhibiting component of tribulin. Medvedev AE; Gorkin VZ; Fedotova IB; Semiokhina AF; Glover V; Sandler M Biochem Pharmacol; 1992 Sep; 44(6):1209-10. PubMed ID: 1417943 [TBL] [Abstract][Full Text] [Related]
33. Effect of dehydroepiandrosterone (DHEA) on monoamine oxidase activity, lipid peroxidation and lipofuscin accumulation in aging rat brain regions. Kumar P; Taha A; Sharma D; Kale RK; Baquer NZ Biogerontology; 2008 Aug; 9(4):235-46. PubMed ID: 18307051 [TBL] [Abstract][Full Text] [Related]
34. Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor. Pisani L; Muncipinto G; Miscioscia TF; Nicolotti O; Leonetti F; Catto M; Caccia C; Salvati P; Soto-Otero R; Mendez-Alvarez E; Passeleu C; Carotti A J Med Chem; 2009 Nov; 52(21):6685-706. PubMed ID: 19810674 [TBL] [Abstract][Full Text] [Related]
35. Monoamine oxidase B (MAO-B) inhibition by active principles from Uncaria rhynchophylla. Hou WC; Lin RD; Chen CT; Lee MH J Ethnopharmacol; 2005 Aug; 100(1-2):216-20. PubMed ID: 15890481 [TBL] [Abstract][Full Text] [Related]
36. A bioluminescent assay for monoamine oxidase activity. Valley MP; Zhou W; Hawkins EM; Shultz J; Cali JJ; Worzella T; Bernad L; Good T; Good D; Riss TL; Klaubert DH; Wood KV Anal Biochem; 2006 Dec; 359(2):238-46. PubMed ID: 17084801 [TBL] [Abstract][Full Text] [Related]
37. Function of endogenous monoamine oxidase inhibitors (tribulin). Glover V J Neural Transm Suppl; 1998; 52():307-13. PubMed ID: 9564631 [TBL] [Abstract][Full Text] [Related]
38. L-methamphetamine and selective MAO inhibitors decrease morphine-reinforced and non-reinforced behavior in rats; Insights towards selegiline's mechanism of action. He S; Grasing K Pharmacol Biochem Behav; 2006 Dec; 85(4):675-88. PubMed ID: 17157368 [TBL] [Abstract][Full Text] [Related]
39. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors. Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910 [TBL] [Abstract][Full Text] [Related]
40. (-)-Trans-epsilon-viniferin, a polyphenol present in wines, is an inhibitor of noradrenaline and 5-hydroxytryptamine uptake and of monoamine oxidase activity. Yáñez M; Fraiz N; Cano E; Orallo F Eur J Pharmacol; 2006 Aug; 542(1-3):54-60. PubMed ID: 16828740 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]